Showing 1,641 - 1,660 results of 6,545 for search '(( significant decrease decrease ) OR ( significantly related decrease ))~', query time: 0.35s Refine Results
  1. 1641
  2. 1642
  3. 1643
  4. 1644
  5. 1645
  6. 1646
  7. 1647
  8. 1648
  9. 1649

    Study Data. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
  10. 1650

    Study outcomes. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
  11. 1651

    Patient characteristics. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
  12. 1652
  13. 1653
  14. 1654
  15. 1655
  16. 1656
  17. 1657
  18. 1658

    The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

    Published 2025
    “…<b>(C, D)</b> Intensity measures of pRPS6 bands relative to the Actin control protein show that Rapamycin (C) and AZD-8055 (D) led to a decrease of phosphorylated RPS6 levels. …”
  19. 1659
  20. 1660